Immunotherapy Associated Neurotoxicity in Pediatric Oncology

Novel immunotherapies are increasingly being employed in pediatric oncology, both in the upfront and relapsed/refractory settings. Through various mechanisms of action, engagement and activation of the immune system can cause both generalized and disease site-specific inflammation, leading to immune...

Descripción completa

Detalles Bibliográficos
Autores principales: Shalabi, Haneen, Nellan, Anandani, Shah, Nirali N., Gust, Juliane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899040/
https://www.ncbi.nlm.nih.gov/pubmed/35265526
http://dx.doi.org/10.3389/fonc.2022.836452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8899040/
https://www.ncbi.nlm.nih.gov/pubmed/35265526
http://dx.doi.org/10.3389/fonc.2022.836452

Ejemplares similares